Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 20, 2015

View Archived Issues

AbbVie presents selective P2X3 receptor antagonists for pain management

La Jolla Pharmaceutical and Vanderbilt University form agreement for BMP type-I receptor inhibitors

The Wistar Institute and OncoCyte to develop diagnostic test for lung cancer

Amgen provides early preclinical data on TRPM8 antagonist for migraine

Ocular-selective oral VEGFR-2 inhibitors for wet AMD reported by Novartis

Edge Therapeutics reports topline phase I/II NEWTON trial data

Resunab granted FDA fast track status for the treatment of systemic sclerosis

Soligenix receives additional NIAID funding to advance heat stable ricin vaccine

FDA grants fast track designation to solithromycin for CABP

Vical's VL-2397 gets FDA QIDP designation

Alkeus provides update on ALK-001 for Stargardt disease

Long-term LATTE results show HIV suppression with two-drug cabotegravir plus rilpivirine regimen

Allergan patent reports formyl peptide modulators

GlaxoSmithKline discloses LRRK2 inhibitors

Boehringer Ingelheim divulges BTK inhibitors

TP Therapeutics patent details apoptosis inducers

Janssen terminates HMPL-507 agreement with Hutchison MediPharma

FDA awards rare pediatric disease designations to idebenone and drisapersen for DMD

Prostate cancer vaccine MVI-816 enters phase I/II trial in combination with pembrolizumab

CureXcell not expected to meet primary endpoint in pivotal venous leg ulcer trial

Vernalis discloses strategy for development of V-158866

EnGeneIC begins phase I Tailored-EDV trial in solid tumors

Vivozon starts phase II trial of analgesic candidate VVZ-149

PDE10A inhibitor TAK-063 enters phase II trial in schizophrenia

Threshold's TH-4000 enters phase II trial in squamous cell carcinoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...